Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

Our Team - Teresa Leezer

Teresa Leezer

   Teresa Leezer
Vice President
502-569-1020 x301
tleezer@metacyte.biz

Teresa Leezer brings over fifteen years of executive management experience from Hoffman-LaRoche, Merck Labs and Bristol Myers Squibb respectively. Her expertise includes the management of business units, portfolios and products in every phase of the life cycle - from pre-clinical, to launch, growth and maturity. Her Fortune 100 pharmaceutical experience in sales, marketing and management spans the institutional, physician and over the counter markets. Estimated launch product sales exceed $7 billion including worldwide blockbusters such as Fosamax, Zantac, Reyataz, Sustiva, Aleve and Rocephin.

Teresa's expertise includes over ten categories of medicine: osteoporosis, oncology, virology, anti-infectives, rheumatology, anesthesiology, dermatology, and pain management. She has directed significant co-marketing initiatives including the co-promotion of Zantac with Roche and Glaxo and the co-promotion of Fosamax with Merck and Wyeth-Ayerst. Teresa has also managed contract sales organizations for the promotion of products such as Flonase and Aleve.

Ms. Leezer is the project director for the following MetaCyte portfolio companies: AllTranz, AppoImmune, Innorem and RhinoCyte. She also serves on the management team for Pradama. She has secured development capital in excess of $10M from venture, federal and angel financing.

Teresa received a Bachelor of Applied Science and a Masters of Business Administration from the University of Louisville. She attended City University, London, England. Teresa has completed Executive Management Programs at Columbia University and the University of Pennsylvania Wharton School of Business.

Ms. Leezer currently serves on the boards of RhinoCyte, Inc. a start-up pharmaceutical company that develops innovative autologous adult human cell solutions to treat a variety of neurodegenerative disorders.; AllTranz, Inc., a start-up pharmaceutical company that develops prodrug strategies that work with a range of dermal products to increase absorption through the skin; InnoRem, Inc. a start-up health science company that develops pharmaceutical and delivery devices for cardiovascular disease, the Healthcare Enterprise Fellows dedicated to building a viable healthcare professionals network in the Louisville metropolitan area, LouHIE, a non-profit organization dedicated to a community wide health information service in the Louisville metropolitan area; the Ronald McDonald House, a non-profit agency that provides services to over 10,000 families with critically ill children in the Louisville region and the St. Francis of Assisi School Board.

See also: Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

See also: Teresa Leezer Honored a Second Time for Excellence in Business Management







July 16, 2010
Intrepid Bioinformatics Receives Investment, Meets Milestones

May 6, 2010
MetaCyte Business Lab Receives Mention in Nature (PDF)

March 31, 2010
MetaCyte Recognized for Innovation

March 15, 2010
Teresa Leezer Honored a Second Time for Excellence in Business Management

February 23, 2010
Gailar Addresses Leaders as Part of Innovation Panel

January 2010
Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

November 2009
MetaCyte Advisor Bill Strench Featured in Business First (External Link)

November 2009
EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

August 25, 2009
Pierce Named Interim Head of UofL Research (External Link)

July 1, 2009
AllTranz Named Top Innovator by National Venture Group

May 8, 2009
ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

September 12, 2008
MetaCyte Team Shows Off New Offices

June 18, 2008
Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

Summer 2006
A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)